Research Development - Myomo Inc (F:0M61) - Alpha Spread
Have any thoughts about
Myomo Inc?
Write Note

Myomo Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Myomo Inc
Research & Development Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Myomo Inc
F:0M61
Research & Development
-$3.6m
CAGR 3-Years
-34%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Becton Dickinson and Co
NYSE:BDX
Research & Development
-$1.2B
CAGR 3-Years
0%
CAGR 5-Years
-2%
CAGR 10-Years
-8%
Boston Scientific Corp
NYSE:BSX
Research & Development
-$1.5B
CAGR 3-Years
-8%
CAGR 5-Years
-5%
CAGR 10-Years
-6%
Stryker Corp
NYSE:SYK
Research & Development
-$1.4B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-9%
Abbott Laboratories
NYSE:ABT
Research & Development
-$2.6B
CAGR 3-Years
-1%
CAGR 5-Years
-2%
CAGR 10-Years
-7%
Intuitive Surgical Inc
NASDAQ:ISRG
Research & Development
-$1.1B
CAGR 3-Years
-20%
CAGR 5-Years
-17%
CAGR 10-Years
-20%

See Also

What is Myomo Inc's Research & Development?
Research & Development
-3.6m USD

Based on the financial report for Jun 30, 2024, Myomo Inc's Research & Development amounts to -3.6m USD.

What is Myomo Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-13%

Over the last year, the Research & Development growth was -59%. The average annual Research & Development growth rates for Myomo Inc have been -34% over the past three years , -13% over the past five years .

Back to Top